摘要
目的比较心肌梗死后合并糖尿病及未合并糖尿病患者的QT间期(QTc)及QT离散度(QTcd),并比较心肌梗死后糖尿病患者分别用胰岛素、磺脲类药物、双胍类及饮食控制后的QTc、QTcd。方法138例心肌梗死后患者分为糖尿病组(70例)及非糖尿病组(68例),行同步12导联心电图,测定QTc及QTcd。糖尿病组分别给予胰岛素、磺脲类药物、双胍类及饮食控制后测定QTc及QTcd。结果糖尿病组的QTc、QTcd显著高于非糖尿病组[(377.2±24.3)ms与(342.9±27.5)ms、(48.8±19.7)ms与(40.3±26.6)ms,t分别为7.77、2.14,P〈0.01或0.05],双胍类药物组与饮食控制组QTc、QTcd比较差异无统计学意义(P均〉0.05),胰岛素组QTc、QTcd显著高于其他3纽(P〈0.05或0.01),磺脲类药物组QTc、QTcd高于双胍类药物组及饮食控制组(P〈0.05或0.01)。结论心肌梗死后糖尿病患者QTcd增加,提示心肌梗死后糖尿病患者的病死率高。胰岛素和格列吡嗪可能会增加心肌梗死后糖尿病患者QTcd,且在胰岛素治疗后更明显。
Objective To compare the QTc and QTcd between type 2 diabetic and non-diabetic patients with post-myocardial infarction (post-MI) ,and to compare the QTcd in type 2 diabetic patients with post-MI treated with insulin, sulfonylurea, metformin, or diet alone. Methods We measured the QTc and QTcd through simultaneous 12-lead Electrocardiogram in 138 post-MI patients,including 70 type 2 diabetic (of which,23 were assigned to receive insulin ,20 glipizide, 16 metformin, 11 diet control) and 68 non-diabetic patients. Result Compared with post- MI patients without diabetes, those with type 2 diabetes had significantly higher QTc [ ( 377.2 ± 24. 3 ) ms vs (342.9 ±27.5)ms,t =7.79,P 〈0.01 ] and QTcd [ (48.8 ± 19.7)ms vs (40.3 ±26.6)ms,t =2.14,P 〈0.05]. There were no significant difference between the metformin group and the diet control group ( P 〉 0.05 ). The QTc and QTed in the insulin group were significantly higher than those in the other three group s (P 〈 0.05 ), and the QTc and QTed in the glipizide group were higher than those in the metformin group or diet control group ( P 〈 0.05, and P 〈 0.01 ,respectively). Conclusion Type 2 diabetes is associated with an additional increase in the QTed in post- MI patients,suggesting higher mortality risk in post-MI patients with type 2 diabetes. Insulin and glipizide may increase the QTc and QTed in post-MI patients with diabetes. These effects were more significant in the insulin therapy group.
出处
《中国综合临床》
2009年第7期706-708,共3页
Clinical Medicine of China
关键词
QT间期离散度
心肌梗死
2型糖尿病
降糖药物
QT-interval dispersion
Myocardial infarction
Type 2 diabetes
Hypoglycemic drugs